(Alliance News) - Shepherd Neame Ltd on Friday said sales over the festive period "remained strong", with the company expecting an easing of sector headwinds throughout 2026. Read More
RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Corxel Pharmaceuticals Ltd, RTW's largest private investment, has completed Series D-1 financing worth USD287 million. Says Corxel is a clinical-stage biopharmaceutical company developing therapies for cardiometabolic conditions, and its lead candidate, CX11, is an oral GLP-1 receptor agonist for obese and overweight patients currently in a phase 2 US trial. Expects the financing proceeds to support the advancement of this trial, as well as a planned global phase 2 trial in type 2 diabetes mellitus and initial preparations for phase 3 studies and other cardiometabolic programmes. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Baillie Gifford US Growth Trust PLC on Friday said it believes it is well positioned for future growth as its net asset value grew, though its return was less than the S&P 500 index. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More
Pets At Home Group PLC - Cheshire, England-based operator of pet care centres and veterinary practices - Confirms that Sarah Pollard will join as chief financial officer designate on March 23. Current CFO Mike Iddon will step down from the board on March 27, when Pollard will succeed him as CFO & executive director. Pets At Home says Iddon will stay at the company until April 10 to facilitate an orderly transition. It previously announced in late September that Pollard, currently CFO at Manchester-based consumer goods firm PZ Cussons PLC, would be joining as CFO and that it would confirm her appointment date in due course. Pets At Home also said Iddon would remain in post until spring this year. He joined as CFO in 2016, having previously spent two years as CFO of fashion retailer New Look. Read More
Investec PLC and Ltd - Sandton-based financial services company - Announces that the maximum acceptance amounts to GBP300.0 million after a cash tender offer of callable fixed rate resettable subordinated notes. The lender on Thursday launched an offer to buy back up to GBP350.0 million of its outstanding 2.6% callable, fixed-rate resettable subordinated notes due 2032. Investec offered a purchase price of around 99% of principal, plus accrued interest, with any notes acquired to be cancelled. The group said on Thursday that the offer formed part of the proactive management and optimisation of its debt profile. Read More
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More
(Alliance News) - C&C Group PLC on Friday reported weak trading in the period leading up to Christmas due to tepid consumer confidence amid UK budget nerves. Read More
(Alliance News) - Valterra Platinum Ltd on Friday said it expects its annual earnings to surge, getting a boost from a robust platinum group metal price and lower operational costs. Read More
GSK PLC - London-based pharmaceuticals company - Says China's National Medical Products Administration has approved Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, or FF/UMEC/VI) in a new indication, for adults with uncontrolled asthma. This adds to the therapy's current licence for use in chronic obstructive pulmonary disease, and makes it the first and only single inhaler triple therapy approved for the maintenance treatment of both respiratory conditions in China. GSK says approval was based on its Captain study, "which showed that in patients uncontrolled on inhaled corticosteroids/long-acting beta agonist (ICS/LABA), the additional bronchodilation provided by FF/UMEC/VI demonstrated significant improvements in lung function compared with FF/VI." Says asthma is one of the most prevalent chronic respiratory diseases in China, with around 46 million adults affected and approximately half of patients experiencing uncontrolled symptoms. Read More
(Alliance News) - Babcock International Group PLC on Friday announced that its chief executive officer is stepping down, and said it is confident in delivering on expectations for the full year. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
(Alliance News) - HSBC Holdings PLC on Friday noted that the High Court sanctioned the privatisation of Hang Seng Bank Ltd. Read More
(Alliance News) - The growth in UK's service and manufacturing sectors accelerated in January, flash data published by S&P Global showed Friday, though cost pressure intensified. Read More